Company / EPS (Basic)
Quest Diagnostics EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$7.59
FY2025
5-year range
$6.36 / $15.85
FY2021-FY2025
Trend
-6.3%
vs FY2024
Sector context
#21 of 160
Health Care
What the data says
Quest Diagnostics's eps (basic) of $7.59 is higher than 87% of companies in the Health Care sector (FY2025). EPS (Basic) has fluctuated over the past 10 years, ranging from $3.83 in FY2016 to $15.85 in FY2023.
Based on SEC 10-K filings.
7.59 in FY2025 with a 5-year CAGR of +7.1%. Top quartile in the Health Care sector.
Declined from $15.85 to $7.59 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -10.6%
- 5-Year CAGR
- +7.1%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 160This company $7.59 Sector average $1.57
▼
+382.1% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 6.3% year-over-year.
- Ranks #21 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2023.
- Lowest eps (basic) in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.59 | -6.3% |
| FY2024 | $8.10 | -48.9% |
| FY2023 | $15.85 | +49.2% |
| FY2022 | $10.62 | +67.0% |
| FY2021 | $6.36 | +18.0% |
| FY2020 | $5.39 | -4.3% |
| FY2019 | $5.63 | +22.9% |
| FY2018 | $4.58 | -6.9% |
| FY2017 | $4.92 | +28.5% |
| FY2016 | $3.83 | -31.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026